Skip to main content
رجوع
IRMD logo

IRadimed Corporation

جودة البيانات: 100%
IRMD
NASDAQ Healthcare Medical - Devices
KWD 101.78
▲ KWD 0.81 (0.80%)
القيمة السوقية: 1.30B
نطاق اليوم
KWD 101.10 KWD 103.02
نطاق 52 أسبوعًا
KWD 47.48 KWD 107.90
حجم التداول
50,204
متوسط 50 يوم / 200 يوم
KWD 100.42 / KWD 81.20
الإغلاق السابق
KWD 100.97

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (631 نظير)

المقياس السهم وسيط القطاع
P/E 57.9 0.2
P/B 13.8 3.0
ROE % 24.8 3.5
Net Margin % 26.8 3.8
Rev Growth 5Y % 19.0 9.7
D/E 0.0 0.2

السعر المستهدف للمحللين

Hold
KWD 120.00 +17.9%
مكرر الربحية المستقبلي
48.93
ربحية السهم المستقبلية
KWD 2.08
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
91.92M

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2027 KWD 2.32
KWD 2.30 – KWD 2.34
101.14M 1
FY2026 KWD 2.08
KWD 2.07 – KWD 2.09
91.92M 1

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-10 KWD 0.48 KWD 0.54 +12.5%
2025-11-03 KWD 0.48 KWD 0.47 -2.1%
2025-08-01 KWD 0.45 KWD 0.49 +8.9%
2025-05-05 KWD 0.43 KWD 0.42 -2.3%
2025-02-13 KWD 0.45 KWD 0.44 -2.2%
2024-10-31 KWD 0.39 KWD 0.43 +10.3%
2024-08-01 KWD 0.37 KWD 0.42 +13.5%
2024-05-02 KWD 0.34 KWD 0.36 +5.9%

Dividend History

4 yr streak

Yield

0.01%

Payout Ratio

0.67%

Growth (3Y)

5.67%

Growth (5Y)

N/A

Ex-Date Payment Date Amount Yield
Feb 23, 2026 Mar 06, 2026 KWD 0.20 1.20%
Dec 17, 2025 Dec 30, 2025 KWD 0.50 1.26%
Nov 14, 2025 Nov 25, 2025 KWD 0.17 0.81%
Aug 18, 2025 Aug 28, 2025 KWD 0.17 0.94%
May 20, 2025 May 30, 2025 KWD 0.17 1.20%
Feb 24, 2025 Mar 05, 2025 KWD 0.17 1.12%
Nov 15, 2024 Nov 25, 2024 KWD 0.15 0.87%
Aug 20, 2024 Aug 30, 2024 KWD 0.15 2.11%
May 17, 2024 May 30, 2024 KWD 0.15 1.86%
Dec 21, 2023 Jan 12, 2024 KWD 0.63 1.37%
Feb 10, 2023 Feb 21, 2023 KWD 1.05 2.91%
Feb 16, 2022 Feb 24, 2022 KWD 1.00 2.02%

النقاط الرئيسية

Revenue grew 18.99% annually over 5 years — strong growth
Earnings grew 16.88% over the past year
ROE of 24.78% indicates high profitability
Net margin of 26.82% shows strong profitability
Debt/Equity of 0.00 — conservative balance sheet
Generating 17.18M in free cash flow

النمو

Revenue Growth (5Y)
18.99%
Revenue (1Y)14.43%
Earnings (1Y)16.88%
FCF Growth (3Y)77.43%

الجودة

Return on Equity
24.78%
ROIC20.73%
Net Margin26.82%
Op. Margin31.20%

الأمان

Debt / Equity
0.00
Current Ratio7.98
Interest Coverage0.00

التقييم

P/E Ratio
57.87
Forward P/E48.93
P/B Ratio13.75
EV/EBITDA47.80
Dividend Yield0.01%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 14.43% Revenue Growth (3Y) 13.07%
Earnings Growth (1Y) 16.88% Earnings Growth (3Y) 14.35%
Revenue Growth (5Y) 18.99% Earnings Growth (5Y) 24.60%
Profitability
Revenue (TTM) 83.81M Net Income (TTM) 22.48M
ROE 24.78% ROA 20.67%
Gross Margin 76.75% Operating Margin 31.20%
Net Margin 26.82% Free Cash Flow (TTM) 17.18M
ROIC 20.73% FCF Growth (3Y) 77.43%
Safety
Debt / Equity 0.00 Current Ratio 7.98
Interest Coverage 0.00
Dividends
Dividend Yield 0.01% Payout Ratio 0.67%
Dividend Growth (3Y) 5.67% Dividend Growth (5Y) N/A
Consecutive Div Years 4 yrs
Valuation
P/E Ratio 57.87 Forward P/E 48.93
P/B Ratio 13.75 P/S Ratio 15.52
PEG Ratio 3.35 Forward PEG N/A
EV/EBITDA 47.80 Fwd EV/EBITDA 33.37
Forward P/S 14.15 Fwd Earnings Yield 2.04%
FCF Yield 1.32%
Market Cap 1.30B Enterprise Value 1.25B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 83.81M 73.24M 65.56M 53.30M 41.81M
Net Income 22.48M 19.23M 17.19M 12.83M 9.33M
EPS (Diluted) 1.75 1.50 1.35 1.02 0.74
Gross Profit 64.32M 56.35M 50.16M 41.28M 32.05M
Operating Income 26.15M 21.96M 20.04M 15.63M 9.82M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 108.78M 98.33M 92.16M 85.51M 82.88M
Total Liabilities 14.16M 11.51M 20.74M 11.84M 10.71M
Shareholders' Equity 94.62M 86.82M 71.42M 73.67M 72.17M
Total Debt 0.0 154,688.0 2.04M 2.21M 2.48M
Cash & Equivalents 51.16M 52.23M 49.76M 57.96M 62.00M
Current Assets 81.20M 75.24M 76.00M 77.49M 76.24M
Current Liabilities 10.18M 8.51M 16.33M 8.55M 6.82M

درجات الاستراتيجيات

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
#152 of 158
15

النشاط الأخير

دخل Growth Investing (Philip Fisher)
Mar 24, 2026